Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Cell Chemical Biology|February 2, 2024
Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancerTinslee Dilday, Melissa Abt, Nicole Ramos-Solís, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2020
Amine skeleton-based c-di-GMP derivatives as biofilm formation inhibitorsKentaro Ikeda, Yuta Yanase, Katsuhiko Hayashi, et al.
Pharmacology & Therapeutics|January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesAlfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Bioorganic & Medicinal Chemistry|May 21, 2013
Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2'-F-c-di-GMPJie Zhou, Sarah Watt, Jingxin Wang, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Bacterial Cyclic Dinucleotides and the cGAS-cGAMP-STING Pathway: A Role in Periodontitis?Samira Elmanfi, Mustafa Yilmaz, Wilson W S Ong, et al.
Future Medicinal Chemistry|February 14, 2018
Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell linesNeetu Dayal, Clement Opoku-Temeng, Delmis E Hernandez, et al.
Anaerobe|August 20, 2017
Dipeptidyl peptidase IV and quorum sensing signaling in biofilm-related virulence of Prevotella aurantiacaDareen Fteita, Ahmed Ali Musrati, Eija Könönen, et al.
Frontiers in Drug Discovery|April 13, 2026
Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell modelAbigail Haffner, Manoel Figueiredo Neto, C Samuel Umbaugh, et al.
RSC Medicinal Chemistry|October 18, 2024
Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PROTAC deliveryMiyako Naganuma, Nobumichi Ohoka, Motoharu Hirano, et al.
Pageof 22